Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

“Why not get a vaccine that’s going to help you reduce that risk?” The CDC urges both an updated COVID-19 shot and yearly flu ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The seasonal flu places a significant burden on healthcare systems globally, leading to over five million hospitalizations ...

The flu vaccine benefits you by protecting you and the people you live with or spend significant time around. Everyone 6 ...

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC ... confirming that the event was not related to the investigational ...

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...

Human-to-human transmission is very rare, but as cases among animals rise, many experts are worried the virus could develop ...